Fundraising Fox

Lightstone Ventures β€” 2015 Investments

6 investments dated 2015 Β· listed companies and verified rows first Β· show all

Catalyst Biosciences Inc.Jan 2015SEC filingmedium confidence

BiotechSouth San Fransicso, US

Nassim Usman(Executive Officer, Director)

BoardAugustine Lawlor(Director)Ralph Christoffersen(Director)inJeff Himawan(Director)Michael Powell(Director)Asish Xavier(Director)

Board seatRalph (Chris) ChristoffersenΒ· per SEC Form D Β· $5M raise Β· filed Feb 2015

Co-investorsResearch Corporation Technologies

Gynesonicsgynesonics.comin𝕏Apr 2015acquired by Hologic

FemTechHealthtechMedical DevicesRedwood City, US

Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)

BoardKen Haas(Director)Jonathan MacQuitty(Director)inDoug Fisher(Director)

Board seatMike CarusiΒ· per SEC Form D

Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+5 more

Kona MedicalAug 2015SEC filingmedium confidence

BiotechBellevue, US

Michael Gertner(Executive Officer, Director)

BoardLouis Cannon(Director)Christopher Shen(Director)Immanuel Thangaraj(Director)Brian Halak(Director)in

Board seatHenry A. Plain, Jr.Β· per SEC Form D Β· $22.4M raise Β· filed Sep 2015

Co-investorsDomain Associates

Miramar LabsDec 2015SEC filingmedium confidence

HealthtechSanta Clara, US

R. Michael Kleine(Executive Officer, Director)Brigid Makes(Executive Officer)Steven Kim(Executive Officer)

BoardHanson Gifford III(Director)Henry Plain, Jr.(Director)Nimesh Shah(Director)

Board seatHanson S. GiffordΒ· per SEC Form D Β· $33.6M raise Β· filed Jun 2016

Co-investorsDomain Partners

Twelvetwelve.coin𝕏Apr 2015

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder & CEO)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Board seatHanson S. GiffordHenry A. Plain, Jr.Β· per SEC Form D

Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+15 more

Ra Pharmaceuticalsrapharma.comin𝕏Jul 2015

BiotechCambridge, US

Douglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)

BoardEdward Mathers(Director)Rajeev Shah(Director)inPeter Bisgaard(Director)Jason Lettman(Director)

Co-investorsNew Enterprise Associates (NEA)RA Capital

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.